According to an American Association for Cancer Research (AACR) press release, new research presented at the AACR 101st Annual Meeting 2010 suggests the type 2 diabetes drug may soon be used in the prevention of lung cancer....
Category: Products & Tech
The Food and Drug Administration (FDA) is considering stopping a safety study involving thousands of patients taking GlaxoSmithKline PLC's Avandia according to the Wall Street Journal. Avandia has been linked to an increased risk of heart attack. If the trial is stopped, the FDA will also consider asking Glaxo to stop selling the drug, a decision that could also...
Sanofi-aventis announced the results of the first placebo-controlled study of the GetGoal Phase III clinical trial program of lixisenatide (AVE0010), a once-daily GLP-1 agonist developed for patients with type 2 diabetes.
The 12-week study involved 361 patients with type 2 diabetes not currently receiving glucose-lowering therapy and with HbA1c between 7 and 10%...
Roche announced the acquisition of Medingo Ltd., a company engaged in the development of a semi-disposable insulin patch pump.
The new Medingo Ltd. micro pump insulin delivery system consists of two parts: a semi-disposable insulin dispensing patch and a remote control, which allows for discreet personalized insulin delivery...
I love problem solving and thinking about how we can make diabetes as minimally intrusive as possible...
Sanofi-aventis announced that they have signed an agreement with AgaMatrix Inc. for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes care with the aim to simplify patients’ and healthcare providers’ diabetes management experience....
According to a Novo Nordisk announcement the results from their LEAD™ 6 extension study show that switching to once-daily Victoza® (Liraglutide [rDNA Origin] Injection) from exenatide improves blood sugar control in patients with type 2 diabetes.
The study published online in Diabetes Care evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza...
Leptin, a hormone discovered in 1994 by Rudolph L. Leibel, is produced by fat cells. Leptin plays an important role in regulating appetite and in glucose and fat metabolism. Its discovery pioneered the concept that adipose tissue is not a silent energy-storage organ, but actually an active endocrine organ...
I was surprised to learn that there are nearly as many adults diagnosed each year with type 1 as there are children...
Takeda Pharmaceutical Company Limited announced today that its wholly-owned subsidiary Takeda Global Research & Development Centre (Europe) Ltd. withdrew a European Marketing Authorization Application (MAA) for Competac...